These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9563663)

  • 1. The current role of local intratympanic gentamicin therapy in the management of unilateral Menière's disease.
    Pfleiderer AG
    Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):34-41. PubMed ID: 9563663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for intractable Meniere's disease: 5-year follow-up.
    Atlas J; Parnes LS
    J Otolaryngol; 2003 Oct; 32(5):288-93. PubMed ID: 14974857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease.
    Bodmer D; Morong S; Stewart C; Alexander A; Chen JM; Nedzelski JM
    Otol Neurotol; 2007 Dec; 28(8):1140-4. PubMed ID: 18084826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide.
    Yamazaki T; Hayashi M; Komatsuzaki A
    Acta Otolaryngol Suppl; 1991; 481():613-6. PubMed ID: 1927484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results.
    Driscoll CL; Kasperbauer JL; Facer GW; Harner SG; Beatty CW
    Laryngoscope; 1997 Jan; 107(1):83-9. PubMed ID: 9001270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM; Nedzelski JM; Al-Abidi A; Chen JM; Shipp DB
    J Otolaryngol; 2002 Apr; 31(2):106-11. PubMed ID: 12019738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of intratympanic gentamicin in Meniere's disease.
    Diamond C; O'Connell DA; Hornig JD; Liu R
    J Otolaryngol; 2003 Dec; 32(6):351-61. PubMed ID: 14967079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic gentamicin treatment for unilateral Ménière's disease: long-term follow up of a proven regime.
    Wasson J; Upile N; Pfleiderer A
    J Laryngol Otol; 2013 Jan; 127(1):20-4. PubMed ID: 23217984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamycin in severe Ménière's disease.
    Laitakari K
    Clin Otolaryngol Allied Sci; 1990 Dec; 15(6):545-8. PubMed ID: 2073763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease.
    Thomsen J; Charabi S; Tos M
    Eur Arch Otorhinolaryngol; 2000; 257(7):362-5. PubMed ID: 11052245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic gentamicin treatment for Meniere's disease.
    McFeely WJ; Singleton GT; Rodriguez FJ; Antonelli PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):589-96. PubMed ID: 9591855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
    Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E; Perez N
    Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intratympanic infusion of gentamicin via a microcatheter in Menière's disease.
    Schoendorf J; Neugebauer P; Michel O
    Otolaryngol Head Neck Surg; 2001 Feb; 124(2):203-7. PubMed ID: 11226958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.